Evidence map›Paper›PMID 32132111›Full record

ArticleCancer research2020

A Protease-Activated Fluorescent Probe Allows Rapid Visualization of Keratinocyte Carcinoma during Excision.

Ethan Walker, Yiqiao Liu, InYoung Kim, Mark Biro, Sukanya Raj Iyer, Harib Ezaldein, Jeffrey Scott, Miesha Merati, Rachel Mistur, Bo Zhou and 7 more

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. A Cathepsin-Targeted Quenched Activity-Based Probe Facilitates Enhanced Detection of Human Tumors during Resection.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Ethan Walker *Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.
Yiqiao Liu *Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.
InYoung Kim *Department of Dermatology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio.
Mark BiroCase Western Reserve University School of Medicine, Cleveland, Ohio.
Sukanya Raj IyerDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.
Harib EzaldeinDepartment of Dermatology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio.ORCID 0000-0001-8489-4264
Jeffrey ScottDepartment of Dermatology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio.
Miesha MeratiDepartment of Dermatology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio.
Rachel MisturDepartment of Dermatology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio.
Bo ZhouDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.
Brian StraightAkrotome Imaging Inc., Cleveland, Ohio.
Joshua J YimChemical and Systems Biology, Stanford University, Palo Alto, California.
Matthew BogyoChemical and Systems Biology, Stanford University, Palo Alto, California.
Margaret MannDepartment of Dermatology, Case Western Reserve University, Cleveland, Ohio.
David L Wilson *Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.ORCID 0000-0001-9763-1463
James P Basilion *Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio. daniel.popkin@gmail.com jxb206@case.edu.
Daniel L Popkin *Department of Dermatology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio. daniel.popkin@gmail.com jxb206@case.edu.
Case Western Reserve University · USLouis Stokes Cleveland VA Medical Center · USPalo Alto University · USAkrotome Imaging (United States) · USUniversity School · US

Funding

Vitamin D endocrine system and Protection Against Skin TumorlgenesisP30AR039750 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI COOPER, KEVIN D · 1988 to 2015
$9.1M
Intraoperative assessment of non-melanoma skin cancer margins using NIRF probes.R44CA180296 · NCI · AKROTOME IMAGING, INC. · PI STRAIGHT, BRIAN · 2015 to 2016
$1.7M
Combating persistent viral infections using cell specific therapiesI01BX002719 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI POPKIN, DANIEL LEWIS · 2016 to 2018
–
BLRD VA I01 BX002719NCI NIH HHS R44 CA180296NIAMS NIH HHS P30 AR039750
6 · The paper itself

Abstract

Keratinocyte carcinomas, including basal and squamous cell carcinomas, are the most common human cancers worldwide. While 75% of all keratinocyte carcinoma (4 million annual cases in the United States) are treated with conventional excision, this surgical modality has much lower cure rates than Mohs micrographic surgery, likely due to the bread-loaf histopathologic assessment that visualizes <1% of the tissue margins. A quenched protease-activated fluorescent probe 6qcNIR, which produces a signal only in the protease-rich tumor microenvironment, was topically applied to 90 specimens

Indexed as

AgedAged, 80 and overBasal Cell CarcinomaCarcinoma, Squamous CellDermatologic Surgical ProceduresFemaleHumansKeratinocytesMaleMargins of ExcisionMiddle AgedOptical ImagingSensitivity and SpecificitySkin NeoplasmsSurgery, Computer-Assisted

Identifiers

PMID32132111
PMCPMC7231632
OpenAlexW3009108945

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.